Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Quality Index
Hubei Jumpcan Pharmaceutical Co Ltd cash flow quality index. Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Quality Index of -0.82x as of September 2025. Operating cash flow of CN¥-243.75 Million is below net income of CN¥298.10 Million, suggesting accrual-heavy earnings not yet converted to cash. See 600566 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
Cash flow quality index of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. Historical Cash Flow Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600566 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2000–2025)
Hubei Jumpcan Pharmaceutical Co Ltd cash flow quality index by year from 2000 to 2025. Year-by-year earnings quality comparison for Hubei Jumpcan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Hubei Jumpcan Pharmaceutical Co Ltd cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.67x | CN¥1.20 Billion | CN¥1.78 Billion | ▼ -21.4% |
| 2024 | 0.86x | CN¥2.18 Billion | CN¥2.54 Billion | ▼ -30.1% |
| 2023 | 1.23x | CN¥3.46 Billion | CN¥2.82 Billion | ▲ +1.7% |
| 2022 | 1.21x | CN¥2.62 Billion | CN¥2.17 Billion | ▲ +9.4% |
| 2021 | 1.10x | CN¥1.89 Billion | CN¥1.72 Billion | ▼ -20.9% |
| 2020 | 1.39x | CN¥1.78 Billion | CN¥1.28 Billion | ▲ +5.4% |
| 2019 | 1.32x | CN¥2.15 Billion | CN¥1.62 Billion | ▲ +30.7% |
| 2018 | 1.01x | CN¥1.71 Billion | CN¥1.69 Billion | ▲ +4.3% |
| 2017 | 0.97x | CN¥1.19 Billion | CN¥1.22 Billion | ▼ -0.6% |
| 2016 | 0.98x | CN¥913.10 Million | CN¥934.36 Million | ▲ +3.4% |
| 2015 | 0.94x | CN¥645.48 Million | CN¥683.12 Million | ▼ -20.3% |
| 2014 | 1.19x | CN¥616.11 Million | CN¥519.39 Million | ▲ +66.4% |
| 2013 | 0.71x | CN¥287.16 Million | CN¥402.72 Million | ▲ +1276.0% |
| 2011 | 0.05x | CN¥411.24K | CN¥7.94 Million | ▼ -99.1% |
| 2010 | 6.03x | CN¥51.13 Million | CN¥8.48 Million | ▲ +847.4% |
| 2009 | 0.64x | CN¥4.92 Million | CN¥7.73 Million | ▼ -76.8% |
| 2008 | 2.74x | CN¥23.05 Million | CN¥8.42 Million | ▼ -18.7% |
| 2007 | 3.37x | CN¥36.72 Million | CN¥10.90 Million | ▲ +610.4% |
| 2006 | 0.47x | CN¥4.24 Million | CN¥8.95 Million | ▼ -93.7% |
| 2005 | 7.49x | CN¥63.38 Million | CN¥8.46 Million | ▲ +248.0% |
| 2004 | -5.06x | CN¥-37.74 Million | CN¥7.45 Million | ▼ -1775.7% |
| 2003 | 0.30x | CN¥2.24 Million | CN¥7.42 Million | ▼ -80.9% |
| 2002 | 1.58x | CN¥22.00 Million | CN¥13.89 Million | ▲ +277.6% |
| 2001 | 0.42x | CN¥7.43 Million | CN¥17.70 Million | ▼ -74.3% |
| 2000 | 1.63x | CN¥23.73 Million | CN¥14.55 Million | — |